Avast plc
(the "Company")
8 July 2019
Director/PDMR Shareholding
The below individual acquired shares under the Avast plc Existing Employee Share Plan referred to in the Company's Prospectus. The vesting of the award was conditional on continued employment or other service with the Avast Group.
The Notification of Dealing Form provided in accordance with the requirements of the Market Abuse Regulation in relation to this transaction is set out below:
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||||||||||
|
a) |
Name |
ERWIN GUNST |
||||||||||||||||
|
2 |
Reason for the notification |
|||||||||||||||||
|
a) |
Position/status |
NON EXECUTIVE DIRECTOR |
||||||||||||||||
|
b) |
Initial notification /Amendment |
INITIAL NOTIFICATION |
||||||||||||||||
|
3 |
Details of the issuer |
|||||||||||||||||
|
a) |
Name |
Avast plc |
||||||||||||||||
|
b) |
LEI |
213800IR8G8LC2H4BO27 |
||||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument |
ORDINARY SHARES OF GBP 0.10 EACH IN AVAST PLC (ISIN: GB00BDD85M81)
|
||||||||||||||||
|
b) |
Nature of the transaction |
OPTION EXERCISE AND SUBSEQUENT SALE OF SHARES UNDER THE EXISTING SHARE PLAN |
||||||||||||||||
|
c) |
Price(s) and volume(s) |
OPTION EXERCISE
SALE OF SHARES
|
||||||||||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
SALE OF SHARES
|
||||||||||||||||
|
e) |
Date of the transaction |
3 July 2019 |
||||||||||||||||
|
f) |
Place of the transaction |
OPTION EXERCISE: OUTSIDE A TRADING VENUE SALE OF SHARES: LONDON STOCK EXCHANGE (XLON)
|
||||||||||||||||
Alan Rassaby
Company Secretary
Avast Plc.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
